DRCT Fundamental Analysis - DIRECT DIGITAL HOLDINGS IN-A

Name: DIRECT DIGITAL HOLDINGS IN-A (DRCT) Stock
Brand: DIRECT DIGITAL HOLDINGS IN-A
Rating: 3.5 (3 reviews)

Fundamental Rating

Overall DRCT gets a fundamental rating of 2 out of 10. We evaluated DRCT against 96 industry peers in the Media industry. DRCT has a bad profitability rating. Also its financial health evaluation is rather negative. DRCT has a correct valuation and a medium growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

DRCT had negative earnings in the past year.

DRCT had a negative operating cash flow in the past year.

DRCT had negative earnings in 4 of the past 5 years.

The reported operating cash flow has been mixed in the past 5 years: DRCT reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -41.22%, DRCT is not doing good in the industry: 81.25% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-41.22%
ROE	N/A
ROIC	N/A

ROA(3y)-6.67%

ROA(5y)-5.43%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

DRCT has a Gross Margin (34.05%) which is comparable to the rest of the industry.

DRCT's Gross Margin has declined in the last couple of years.

The Profit Margin and Operating Margin are not available for DRCT so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	34.05%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-16.71%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DRCT does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for DRCT has been increased compared to 1 year ago.

The debt/assets ratio for DRCT is higher compared to a year ago.

2.2 Solvency

DRCT has an Altman-Z score of -1.62. This is a bad value and indicates that DRCT is not financially healthy and even has some risk of bankruptcy.

DRCT's Altman-Z score of -1.62 is on the low side compared to the rest of the industry. DRCT is outperformed by 77.08% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-1.62

ROIC/WACCN/A

WACC11.08%

2.3 Liquidity

DRCT has a Current Ratio of 0.48. This is a bad value and indicates that DRCT is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 0.48, DRCT is doing worse than 85.42% of the companies in the same industry.

DRCT has a Quick Ratio of 0.48. This is a bad value and indicates that DRCT is not financially healthy enough and could expect problems in meeting its short term obligations.

DRCT's Quick ratio of 0.48 is on the low side compared to the rest of the industry. DRCT is outperformed by 85.42% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.48
Quick Ratio	0.48

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

DRCT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.65%, which is quite impressive.

DRCT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -60.35%.

Measured over the past years, DRCT shows a quite strong growth in Revenue. The Revenue has been growing by 17.76% on average per year.

EPS 1Y (TTM)49.65%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%88.46%

Revenue 1Y (TTM)-60.35%

Revenue growth 3Y17.76%

Revenue growth 5YN/A

Sales Q2Q%-12.02%

3.2 Future

Based on estimates for the next years, DRCT will show a very strong growth in Earnings Per Share. The EPS will grow by 47.45% on average per year.

Based on estimates for the next years, DRCT will show a quite strong growth in Revenue. The Revenue will grow by 20.00% on average per year.

EPS Next Y87.74%

EPS Next 2Y47.45%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year6.44%

Revenue Next 2Y20%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

DRCT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

The Price/Forward Earnings ratio is 0.31, which indicates a rather cheap valuation of DRCT.

Compared to the rest of the industry, the Price/Forward Earnings ratio of DRCT indicates a rather cheap valuation: DRCT is cheaper than 100.00% of the companies listed in the same industry.

DRCT is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.98, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	0.31

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

DRCT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as DRCT's earnings are expected to grow with 47.45% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y47.45%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for DRCT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DIRECT DIGITAL HOLDINGS IN-A

NASDAQ:DRCT (11/19/2025, 2:58:19 PM)

0.1572

-0.01 (-8.71%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryMedia

Earnings (Last)11-06 2025-11-06/amc

Earnings (Next)03-25 2026-03-25/amc

Inst Owners3.64%

Inst Owner Change-28.5%

Ins Owners3.63%

Ins Owner Change16.87%

Market Cap4.03M

Revenue(TTM)62.29M

Net Income(TTM)-9.48M

Analysts80

Price Target6.12 (3793.13%)

Short Float %10.22%

Short Ratio0.25

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-3354.62%

Min EPS beat(2)-6762.75%

Max EPS beat(2)53.51%

EPS beat(4)1

Avg EPS beat(4)-2084.79%

Min EPS beat(4)-6762.75%

Max EPS beat(4)53.51%

EPS beat(8)2

Avg EPS beat(8)-1048.56%

EPS beat(12)3

Avg EPS beat(12)-707.85%

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-15.43%

Min Revenue beat(2)-15.98%

Max Revenue beat(2)-14.88%

Revenue beat(4)0

Avg Revenue beat(4)-37.87%

Min Revenue beat(4)-85.1%

Max Revenue beat(4)-14.88%

Revenue beat(8)1

Avg Revenue beat(8)-22.07%

Revenue beat(12)5

Avg Revenue beat(12)-7.76%

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-108.82%

EPS NY rev (1m)0%

EPS NY rev (3m)45.67%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-36.16%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-22.49%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	0.31
P/S	0.11
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-1.23

EYN/A

EPS(NY)0.5

Fwd EY317.94%

FCF(TTM)-0.16

FCFYN/A

OCF(TTM)-0.16

OCFYN/A

SpS1.42

BVpS-0.43

TBVpS-1.03

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-41.22%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	34.05%
FCFM	N/A

ROA(3y)-6.67%

ROA(5y)-5.43%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-16.71%

GM growth 5YN/A

F-Score2

Asset Turnover1.59

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	2.23%
Cap/Sales	0.14%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.48
Quick Ratio	0.48
Altman-Z	-1.62

F-Score2

WACC11.08%

ROIC/WACCN/A

Cap/Depr(3y)14.58%

Cap/Depr(5y)N/A

Cap/Sales(3y)0.31%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)49.65%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%88.46%

EPS Next Y87.74%

EPS Next 2Y47.45%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-60.35%

Revenue growth 3Y17.76%

Revenue growth 5YN/A

Sales Q2Q%-12.02%

Revenue Next Year6.44%

Revenue Next 2Y20%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-60.27%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year91.3%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-192.97%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-177.29%

OCF growth 3YN/A

OCF growth 5YN/A

DIRECT DIGITAL HOLDINGS IN-A / DRCT FAQ

What is the fundamental rating for DRCT stock?

ChartMill assigns a fundamental rating of 2 / 10 to DRCT.

Can you provide the valuation status for DIRECT DIGITAL HOLDINGS IN-A?

ChartMill assigns a valuation rating of 4 / 10 to DIRECT DIGITAL HOLDINGS IN-A (DRCT). This can be considered as Fairly Valued.

What is the profitability of DRCT stock?

DIRECT DIGITAL HOLDINGS IN-A (DRCT) has a profitability rating of 1 / 10.

Can you provide the expected EPS growth for DRCT stock?

The Earnings per Share (EPS) of DIRECT DIGITAL HOLDINGS IN-A (DRCT) is expected to grow by 87.74% in the next year.

DIRECT DIGITAL HOLDINGS IN-A (DRCT) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

DIRECT DIGITAL HOLDINGS IN-A / DRCT FAQ

What is the fundamental rating for DRCT stock?

Can you provide the valuation status for DIRECT DIGITAL HOLDINGS IN-A?

What is the profitability of DRCT stock?

Can you provide the expected EPS growth for DRCT stock?